American Diabetes Association

660 articles with American Diabetes Association

• ADA Names Charles D. Henderson as New Chief Executive Officer

  5/12/2022

  The American Diabetes Association®, the nation's leading voluntary health organization fighting to bend the curve on the diabetes epidemic, is proud to announce Charles D. "Chuck" Henderson as the new Chief Executive Officer.

• American Diabetes Association Secures $3.25M to Support the Next Generation of Trailblazers in Diabetes Research

  4/25/2022

  The American Diabetes Association® is pleased to announce the opening of a new nomination window for the Pathway to Stop Diabetes® research grants in 2022.

• American Diabetes Association Teams Up With Dr. Comfort To Take Next Step in Preventing and Managing Foot Complications

  2/8/2022

  Every four minutes, an American loses a limb due to diabetes—a complication that could be preventable when given the right tools.

• Important Discoveries in Diabetes Highlighted in American Diabetes Association 2021 Research Report

  2/7/2022

  The American Diabetes Association® released its diabetes 2021 Research Report showcasing extraordinary discoveries in the U.S. With over 200 grants currently being managed, the organization's goal is to use research to improve the lives of the 133 million Americans living with diabetes and prediabetes.

• ADA and ADCES Update National Standards for Diabetes Self-Management Education and Support

  1/20/2022

  New updates to the National Standards for Diabetes Self-Management Education and Support call for addressing health equity by improving access to diabetes self-management education and support services, a renewed focus on increasing and maintaining person-centered care and reducing administrative burden.

• American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population

  1/4/2022

  The American Diabetes Association® and Renalytix announced a joint program to improve overall kidney health in patients with type 2 diabetes in the United States, which is expected to grow from 34 million individuals today to nearly 60 million by 20601.

• American Diabetes Association Welcomes 2022 Principal Officers and New Members to National Board of Directors

  12/22/2021

  The American Diabetes Association® welcomes the 2022 Principal Officers and Board of Directors.

• Latest ADA Annual Standards of Care Includes Changes to Diabetes Screening, First-Line Therapy, Pregnancy, and Technology

  12/20/2021

  The American Diabetes Association® released its much-anticipated annual Standards of Medical Care in Diabetes.

• House Embraces Historic Insulin Affordability Measures in Build Back Better Act

  11/19/2021

  The American Diabetes Association® hailed a major national victory when the U.S. House of Representatives passed the Build Back Better Act, including the most sweeping nationwide measure to date to limit out-of-pocket co-pays for insulin.

• Abbott and the American Diabetes Association® Launch First-of-Its-Kind Community Initiative in Columbus, Ohio, to Advance Access to Diabetes Care and Technology

  11/9/2021

  Abbott and the American Diabetes Association® announced the launch of their first joint community health partnership.

• The American Diabetes Association® and DaVita Raise Awareness about the Link between Diabetes and Kidney Disease during American Diabetes Month®

  11/1/2021

  In honor of American Diabetes Month®, the American Diabetes Association® and DaVita are coming together to educate Americans about the connection between diabetes and kidney disease.

• American Diabetes Association Calls for Research Targeting Diabetes Prevention

  9/30/2021

  The American Diabetes Association® announced that applications for grants are being accepted for two new research initiatives, leveraging nutrition and lifestyle for diabetes prevention, and precision medicine to improve the management of diabetes.

• ADA CEO Tracey D. Brown Announces Departure After Transformational Tenure

  8/27/2021

  The American Diabetes Association®, announced that Chief Executive Officer Tracey D. Brown will be leaving the ADA effective October 6, 2021, to take a senior leadership role at Walgreens as President of Retail Products and Chief Customer Officer.

• Leading Diabetes Advocacy Groups Urge CDC to Include Americans with Diabetes in Those Prioritized for COVID-19 Vaccine Boosters

  8/12/2021

  Today, the American Diabetes Association® and 14 other leading voluntary health organizations and medical societies concerned with diabetes urged the Centers for Disease Control and Prevention (CDC) to consider the health risks people with diabetes are facing with COVID-19 as the agency develops guidance on special patient populations who may benefit from additional COVID-19 vaccine doses

• Sanofi Canada continues to invest in modern diabetes research to improve outcomes for people living with diabetes

  7/2/2021

  Building on a strong legacy and history in diabetes, Sanofi Canada participated in the 81st Scientific Sessions hosted by the American Diabetes Association.

• Early Use Of Sotagliflozin Provides Benefits For People With Type 2 Diabetes With Chronic Kidney Disease Or Heart Failure

  6/29/2021

  Results from two large clinical trials show significant and early benefits from sotagliflozin, a drug that inhibits sodium-glucose transport protein 2 and sodium-glucose transport protein 1 in reducing heart failure, heart attack, and stroke—major problems in people with diabetes.

• Hanmi Pharmaceutical finds new innovative potential for "Efpeglenatide"

  6/29/2021

  Hanmi Pharmaceutical recently announced that its new, long-acting diabetes biologic drug, efpeglenatide, was shown to significantly reduce incidences of major adverse cardiovascular events and kidney disease in the results of its global, large-scale clinical trial with more than 4,000 patients.

• The American Diabetes Association and Partners Commemorate 100th Anniversary of Discovery of Insulin and Look to the Next 100 Years for Breakthroughs Ahead

  6/28/2021

  The American Diabetes Association®, along with the nation's leading diabetes organizations, unveiled Let's Talk Insulin , a campaign commemorating the 100th anniversary of the discovery of insulin.

• Liraglutide And Insulin More Effective In Maintaining Average Blood Glucose Levels Than Other Common Diabetes Drugs

  6/28/2021

  Investigators sponsored by the National Institutes of Health announced findings from the largest and longest study comparing the effectiveness of common medications to treat type 2 diabetes.

• New Soliqua 100/33 data shows improved blood sugar control without weight gain versus premixed insulin

  6/28/2021

  A new study of Soliqua® 100/33 100 Units/mL and 33 mcg/mL, iGlarLixi, met its two primary endpoints and all key secondary endpoints in a head-to-head comparison against premixed insulin in adults living with type 2 diabetes, the most common form of diabetes, uncontrolled on insulin and one or two oral anti-diabetic medicines.